Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has a beta value of 1.58 and has seen 12,147,588 shares traded in the last trading session. The company, currently valued at $296.34 Million, closed the last trade at $2.2 per share which meant it gained $0.09 on the day or 4.27% during that session. The CTXR stock price is -31.82% off its 52-week high price of $2.9 and 71.82% above the 52-week low of $0.62. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.83 Million shares traded. The 3-month trading volume is 14.59 Million shares.
The consensus among analysts is that Citius Pharmaceuticals Inc. (CTXR) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.07.
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) trade information
Sporting 4.27% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, Apr 30 when the CTXR stock price touched $2.29-3 or saw a rise of 3.93%. Year-to-date, Citius Pharmaceuticals Inc. shares have moved 115.69%, while the 5-day performance has seen it change 23.6%. Over the past 30 days, the shares of Citius Pharmaceuticals Inc. (NASDAQ:CTXR) have changed 18.92%. Short interest in the company has seen 13.08 Million shares shorted with days to cover at 0.9.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 172.73% from current levels. The projected low price target is $4 while the price target rests at a high of $8. In that case, then, we find that the current price level is +263.64% off the targeted high while a plunge would see the stock lose 81.82% from current levels.
Citius Pharmaceuticals Inc. (CTXR) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +20% over the past 5 years. Earnings growth for 2021 is a modest +42%.
Citius Pharmaceuticals Inc. (NASDAQ:CTXR)’s Major holders
Insiders own 9.14% of the company shares, while shares held by institutions stand at 6.7% with a share float percentage of 7.37%. Investors are also buoyed by the number of investors in a company, with Citius Pharmaceuticals Inc. having a total of 29 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc. (The) with over 755.12 Thousand shares worth more than $770.22 Thousand. As of December 30, 2020, Vanguard Group Inc. (The) held 4.08% of shares outstanding.
The other major institutional holder is HighTower Advisors, LLC, with the holding of over 169.94 Thousand shares as of December 30, 2020. The firm’s total holdings are worth over $173.34 Thousand and represent 0.92% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of December 30, 2020, the former fund manager holds about 2.97% shares in the company for having 550720 shares of worth $561.73 Thousand while later fund manager owns 204.31 Thousand shares of worth $208.4 Thousand as of December 30, 2020, which makes it owner of about 1.1% of company’s outstanding stock.